Clinical Trials Directory

Trials / Completed

CompletedNCT05758649

Cardiovascular and Psychological Consequences of COVID-19

Status
Completed
Phase
Study type
Observational
Enrollment
104 (actual)
Sponsor
Istituti Clinici Scientifici Maugeri SpA · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The study will assess cardiac and psychological profile at 2-3 months after recovery from COVID-19 infection.

Detailed description

A significant proportion of patients hospitalized for COVID-19 showed laboratory signs of myocardial damage, detected by elevated troponin levels, and these were associated with more severe clinical course and higher mortality. Moreover, it is unknown how the health emergency and the associated conditions may have influenced and still influence the psychological experience of the affected people. Thus, in order to promote continuity of care, post-COVID-19 disease clinics have therefore been activated dedicated to a specific follow-up program for monitoring long-term alterations and for the early identification of patients requiring rehabilitation. The program includes a first follow-up visit (2-3 months after recovery) including cardiac (2D-echocardiography, six-minute walking test, autonomic function evaluation) and psychological (Patient Health Questionnaire-9 (PHQ-9) Generalized Anxiety Disorder-7 (GAD) National Stressful Events Survey PTSD Short Scale (NSESSS)) evaluation. A second follow-up visit will be performed at 12 months in the form of structured interview,

Conditions

Timeline

Start date
2020-10-01
Primary completion
2023-12-31
Completion
2024-02-29
First posted
2023-03-07
Last updated
2024-03-06

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT05758649. Inclusion in this directory is not an endorsement.